Trial Profile
Phase II/III induction study of AJG501 in patients with active ulcerative colitis
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 25 May 2016
Price :
$35
*
At a glance
- Drugs Mesalazine (Primary) ; Mesalazine
- Indications Ulcerative colitis
- Focus Therapeutic Use
- Sponsors Ajinomoto Pharma
- 25 May 2016 New trial record